Concepts (241)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Angiography | 6 | 2019 | 1430 | 0.890 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2019 | 4036 | 0.720 |
Why?
|
| Magnetic Resonance Imaging | 14 | 2022 | 36542 | 0.480 |
Why?
|
| Physical Endurance | 1 | 2015 | 368 | 0.410 |
Why?
|
| Fumarates | 1 | 2013 | 132 | 0.400 |
Why?
|
| Renin | 1 | 2013 | 647 | 0.360 |
Why?
|
| Amides | 1 | 2013 | 451 | 0.350 |
Why?
|
| Muscle Contraction | 1 | 2015 | 1206 | 0.350 |
Why?
|
| Atherosclerosis | 7 | 2016 | 3421 | 0.330 |
Why?
|
| Carotid Arteries | 2 | 2012 | 937 | 0.320 |
Why?
|
| Leg | 2 | 2015 | 1108 | 0.320 |
Why?
|
| Aorta, Thoracic | 2 | 2013 | 1110 | 0.290 |
Why?
|
| Whole Body Imaging | 1 | 2010 | 281 | 0.290 |
Why?
|
| Subtraction Technique | 1 | 2010 | 513 | 0.270 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2009 | 520 | 0.260 |
Why?
|
| Contrast Media | 7 | 2018 | 5329 | 0.250 |
Why?
|
| Peripheral Arterial Disease | 2 | 2019 | 1312 | 0.240 |
Why?
|
| Carotid Stenosis | 1 | 2011 | 868 | 0.230 |
Why?
|
| Gadolinium DTPA | 3 | 2012 | 822 | 0.220 |
Why?
|
| Spinal Cord Injuries | 2 | 2009 | 928 | 0.220 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2012 | 3359 | 0.210 |
Why?
|
| Image Enhancement | 3 | 2012 | 2859 | 0.210 |
Why?
|
| Vascular Diseases | 1 | 2011 | 1164 | 0.210 |
Why?
|
| Reproducibility of Results | 9 | 2022 | 20131 | 0.200 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2013 | 1529 | 0.190 |
Why?
|
| Edema | 3 | 2011 | 761 | 0.180 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 4961 | 0.170 |
Why?
|
| Spinal Cord | 1 | 2008 | 1786 | 0.160 |
Why?
|
| Phantoms, Imaging | 4 | 2022 | 2475 | 0.160 |
Why?
|
| Exercise | 1 | 2015 | 5937 | 0.150 |
Why?
|
| Intra-Abdominal Fat | 3 | 2012 | 624 | 0.140 |
Why?
|
| Exercise Test | 2 | 2016 | 2184 | 0.140 |
Why?
|
| Iohexol | 1 | 2018 | 205 | 0.140 |
Why?
|
| Aging | 2 | 2015 | 8731 | 0.140 |
Why?
|
| Thioctic Acid | 1 | 2016 | 28 | 0.130 |
Why?
|
| Phenol | 1 | 2016 | 45 | 0.130 |
Why?
|
| Liposomes | 2 | 2010 | 787 | 0.130 |
Why?
|
| Arteries | 1 | 2019 | 1124 | 0.110 |
Why?
|
| Aorta, Abdominal | 2 | 2013 | 630 | 0.110 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2016 | 385 | 0.100 |
Why?
|
| Algorithms | 2 | 2012 | 14062 | 0.100 |
Why?
|
| Radiation Dosage | 2 | 2018 | 1944 | 0.100 |
Why?
|
| Polylysine | 1 | 2012 | 130 | 0.100 |
Why?
|
| Calgranulin A | 1 | 2012 | 80 | 0.090 |
Why?
|
| Calgranulin B | 1 | 2012 | 87 | 0.090 |
Why?
|
| Retinal Dehydrogenase | 1 | 2011 | 78 | 0.090 |
Why?
|
| Lower Extremity | 1 | 2019 | 1226 | 0.090 |
Why?
|
| Cholesterol Esters | 1 | 2010 | 68 | 0.090 |
Why?
|
| Alginates | 1 | 2012 | 247 | 0.090 |
Why?
|
| Feasibility Studies | 3 | 2012 | 5302 | 0.090 |
Why?
|
| Subcutaneous Fat | 2 | 2011 | 401 | 0.090 |
Why?
|
| Sensitivity and Specificity | 4 | 2015 | 14644 | 0.090 |
Why?
|
| Benzodioxoles | 1 | 2010 | 80 | 0.090 |
Why?
|
| Ischemia | 1 | 2019 | 1922 | 0.090 |
Why?
|
| Observer Variation | 2 | 2013 | 2611 | 0.090 |
Why?
|
| Edema, Cardiac | 1 | 2009 | 19 | 0.090 |
Why?
|
| Captopril | 1 | 2010 | 261 | 0.080 |
Why?
|
| Silicon Dioxide | 1 | 2010 | 218 | 0.080 |
Why?
|
| Single-Blind Method | 1 | 2013 | 1587 | 0.080 |
Why?
|
| Albumins | 1 | 2012 | 577 | 0.080 |
Why?
|
| Myelitis | 1 | 2009 | 49 | 0.080 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2011 | 193 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2008 | 24 | 0.080 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2009 | 116 | 0.080 |
Why?
|
| Chemotaxis | 1 | 2011 | 596 | 0.080 |
Why?
|
| Adipogenesis | 1 | 2011 | 370 | 0.080 |
Why?
|
| Thermogenesis | 1 | 2012 | 497 | 0.070 |
Why?
|
| Phosphatidylserines | 1 | 2008 | 184 | 0.070 |
Why?
|
| Mammography | 1 | 2018 | 2423 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2012 | 403 | 0.070 |
Why?
|
| Neurofibromin 2 | 1 | 2008 | 268 | 0.070 |
Why?
|
| Myocardium | 2 | 2011 | 4763 | 0.070 |
Why?
|
| Inflammation | 3 | 2012 | 10845 | 0.070 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2011 | 317 | 0.070 |
Why?
|
| Neurofibromin 1 | 1 | 2008 | 189 | 0.070 |
Why?
|
| Phenols | 1 | 2010 | 522 | 0.070 |
Why?
|
| Delayed-Action Preparations | 1 | 2010 | 967 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2011 | 1688 | 0.070 |
Why?
|
| Middle Aged | 10 | 2018 | 223016 | 0.060 |
Why?
|
| Carotid Artery Diseases | 1 | 2012 | 878 | 0.060 |
Why?
|
| Disease Progression | 3 | 2016 | 13613 | 0.060 |
Why?
|
| Hyperlipidemias | 1 | 2010 | 770 | 0.060 |
Why?
|
| Disease Models, Animal | 8 | 2016 | 18289 | 0.060 |
Why?
|
| Artifacts | 2 | 2011 | 1893 | 0.060 |
Why?
|
| Cervical Vertebrae | 2 | 2009 | 978 | 0.060 |
Why?
|
| Male | 16 | 2016 | 363740 | 0.060 |
Why?
|
| Female | 16 | 2018 | 396050 | 0.060 |
Why?
|
| Humans | 21 | 2022 | 765823 | 0.060 |
Why?
|
| Linear Models | 2 | 2018 | 5873 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2015 | 2643 | 0.060 |
Why?
|
| Aortic Diseases | 1 | 2010 | 743 | 0.060 |
Why?
|
| Cardiovascular Agents | 1 | 2010 | 850 | 0.060 |
Why?
|
| Immunoconjugates | 1 | 2012 | 979 | 0.060 |
Why?
|
| Predictive Value of Tests | 5 | 2019 | 15398 | 0.060 |
Why?
|
| Antibodies | 1 | 2012 | 2415 | 0.050 |
Why?
|
| Models, Biological | 2 | 2018 | 9441 | 0.050 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2011 | 1092 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 1892 | 0.050 |
Why?
|
| Macrophages | 4 | 2012 | 5771 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2010 | 1514 | 0.050 |
Why?
|
| Gadolinium | 1 | 2008 | 966 | 0.050 |
Why?
|
| Neurilemmoma | 1 | 2008 | 522 | 0.050 |
Why?
|
| Aged | 8 | 2018 | 171178 | 0.050 |
Why?
|
| Aorta | 1 | 2010 | 2037 | 0.050 |
Why?
|
| Neuroma, Acoustic | 1 | 2006 | 456 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 1804 | 0.050 |
Why?
|
| Rabbits | 3 | 2016 | 4731 | 0.050 |
Why?
|
| Monocytes | 1 | 2011 | 2592 | 0.050 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2008 | 952 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2012 | 4160 | 0.050 |
Why?
|
| Mice, Knockout | 6 | 2012 | 14445 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2011 | 2965 | 0.040 |
Why?
|
| Apolipoproteins E | 3 | 2012 | 1458 | 0.040 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2008 | 1456 | 0.040 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2016 | 657 | 0.040 |
Why?
|
| Metabolism | 2 | 2012 | 193 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2011 | 2129 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2013 | 54798 | 0.040 |
Why?
|
| Hemorrhage | 2 | 2009 | 3464 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2013 | 12421 | 0.040 |
Why?
|
| Animals | 14 | 2016 | 168730 | 0.040 |
Why?
|
| Adult | 8 | 2018 | 223055 | 0.040 |
Why?
|
| Particulate Matter | 1 | 2010 | 2624 | 0.040 |
Why?
|
| Vasoconstriction | 2 | 2010 | 594 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 59506 | 0.040 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2018 | 170 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2008 | 3087 | 0.030 |
Why?
|
| Vasodilation | 2 | 2010 | 970 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2010 | 8725 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2016 | 8927 | 0.030 |
Why?
|
| Calibration | 1 | 2018 | 814 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 1481 | 0.030 |
Why?
|
| Mice | 9 | 2016 | 81788 | 0.030 |
Why?
|
| Time Factors | 4 | 2011 | 40109 | 0.030 |
Why?
|
| Cells, Cultured | 4 | 2012 | 18970 | 0.030 |
Why?
|
| Research Design | 1 | 2011 | 6207 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2011 | 22227 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 8039 | 0.030 |
Why?
|
| Rats | 2 | 2009 | 23707 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20680 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 23588 | 0.030 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2016 | 389 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2011 | 4698 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2010 | 1965 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 4 | 2012 | 22323 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 12966 | 0.030 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 1885 | 0.020 |
Why?
|
| Oxidative Stress | 2 | 2016 | 3139 | 0.020 |
Why?
|
| Water | 1 | 2018 | 1417 | 0.020 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2012 | 112 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 14745 | 0.020 |
Why?
|
| CCAAT-Binding Factor | 1 | 2011 | 21 | 0.020 |
Why?
|
| Powder Diffraction | 1 | 2010 | 2 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 21064 | 0.020 |
Why?
|
| Immunohistochemistry | 3 | 2010 | 11033 | 0.020 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2011 | 85 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2011 | 206 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2012 | 521 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2010 | 157 | 0.020 |
Why?
|
| Ohio | 1 | 2011 | 320 | 0.020 |
Why?
|
| Uracil | 1 | 2011 | 210 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2016 | 1114 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2010 | 209 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2010 | 413 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 15881 | 0.020 |
Why?
|
| Porosity | 1 | 2010 | 347 | 0.020 |
Why?
|
| Body Fat Distribution | 1 | 2011 | 246 | 0.020 |
Why?
|
| Response Elements | 1 | 2011 | 307 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2010 | 8278 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2016 | 1870 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2010 | 249 | 0.020 |
Why?
|
| Luciferases | 1 | 2011 | 713 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2011 | 491 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2009 | 11506 | 0.020 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 2008 | 122 | 0.020 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 2008 | 75 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2009 | 380 | 0.020 |
Why?
|
| Obesity | 1 | 2010 | 13078 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2011 | 483 | 0.020 |
Why?
|
| Tretinoin | 1 | 2011 | 524 | 0.020 |
Why?
|
| Schwann Cells | 1 | 2008 | 195 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2012 | 2270 | 0.020 |
Why?
|
| Inhalation Exposure | 1 | 2010 | 432 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2010 | 643 | 0.020 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2008 | 197 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 15645 | 0.020 |
Why?
|
| Insulin Resistance | 2 | 2011 | 3987 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 1524 | 0.020 |
Why?
|
| Cytokines | 2 | 2012 | 7425 | 0.020 |
Why?
|
| Particle Size | 1 | 2010 | 1632 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2011 | 1077 | 0.020 |
Why?
|
| Critical Illness | 1 | 2019 | 2745 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2012 | 934 | 0.020 |
Why?
|
| Cattle | 1 | 2010 | 3801 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 1651 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2010 | 1610 | 0.010 |
Why?
|
| Heart Rate | 1 | 2016 | 4202 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 2470 | 0.010 |
Why?
|
| Software | 1 | 2018 | 4458 | 0.010 |
Why?
|
| Adipocytes | 1 | 2011 | 1193 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1657 | 0.010 |
Why?
|
| Piperidines | 1 | 2011 | 1662 | 0.010 |
Why?
|
| Transfection | 1 | 2010 | 5742 | 0.010 |
Why?
|
| Dietary Fats | 1 | 2010 | 2002 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 2141 | 0.010 |
Why?
|
| Cell Survival | 1 | 2012 | 5747 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2010 | 2487 | 0.010 |
Why?
|
| Molecular Imaging | 1 | 2008 | 822 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 2626 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2006 | 2627 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2012 | 5879 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2009 | 4849 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2008 | 5018 | 0.010 |
Why?
|
| Adiposity | 1 | 2010 | 1890 | 0.010 |
Why?
|
| Acute Disease | 1 | 2011 | 7237 | 0.010 |
Why?
|
| Glucose | 1 | 2011 | 4332 | 0.010 |
Why?
|
| Swine | 1 | 2009 | 5986 | 0.010 |
Why?
|
| Cell Movement | 1 | 2011 | 5190 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 6061 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 10723 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29915 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2006 | 2391 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2011 | 3931 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2010 | 3584 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 7599 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2011 | 5594 | 0.010 |
Why?
|
| Young Adult | 2 | 2016 | 59849 | 0.010 |
Why?
|
| Insulin | 1 | 2010 | 6601 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2010 | 6422 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2011 | 8532 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 15540 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 9594 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 18380 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2011 | 11643 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 11888 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 8601 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2011 | 12122 | 0.010 |
Why?
|
| Brain | 1 | 2018 | 27178 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 17063 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 74853 | 0.000 |
Why?
|
| Adolescent | 1 | 2009 | 88794 | 0.000 |
Why?
|
Concepts
(241)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_